By eigindia For most non–critically ill hospitalized patients with diabetes, one should have a target blood sugar of <180 mg/dL. In non–critically ill hospitalized patients, lower blood glucose levels may decrease the risk of poor clinical outcomes, but also increase the risk of hypoglycemia, which can lead to severe complications such as confusion, seizures, and even coma. Therefore, striking a balance between achieving optimal glucose control and minimizing hypoglycemia is crucial.
Individualized treatment plans are essential, considering factors such as age, comorbidities, and nutritional intake. Frequent blood glucose monitoring and adjusting insulin therapy accordingly can help maintain safe and stable blood sugar levels. Basal-bolus insulin regimens are often preferred over sliding-scale insulin alone, as they provide more consistent glucose control.
The role of the healthcare team is vital in managing diabetes care in hospitalized patients. Endocrinologists, nurses, and dietitians should collaborate to ensure that patients receive comprehensive care. Proper patient education on self-monitoring and recognizing symptoms of both hyperglycemia and hypoglycemia is essential for better outcomes post-discharge.
Additionally, evidence suggests that maintaining blood sugar levels below 180 mg/dL can reduce the risk of infections, delayed wound healing, and longer hospital stays. However, aggressive glucose control without proper monitoring can lead to harmful fluctuations.
In conclusion, achieving a target blood glucose level of <180 mg/dL in non–critically ill hospitalized patients requires a balanced approach, individualized treatment plans, and a collaborative healthcare team effort to ensure patient safety and improved clinical outcomes.